BMP-2-releasing gelatin microspheres/PLGA scaffolds for bone repairment of X-ray-radiated rabbit radius defects
Source abstract
Abstract
The purpose of this research is to assess the feasibility of poly(lactic-co-glycolic) acid (PLGA) incorporating gelatin microspheres (PLGA/GMs scaffold) for enhancing osteogenesis in vitro and at a radius defect of rabbits after X-ray radiation in vivo. After incorporating gelatin microspheres, PLGA scaffold demonstrated improved mechanical properties. Moreover, a sustained release property of recombinant human bone morphogenetic protein-2 (BMP-2) was achieved in BMP-2-releasing PLGA/GMs scaffold. BMP-2-releasing PLGA/GMs scaffold also enhanced proliferation and osteogenesis of rabbit bone mesenchymal stem cells (BMSCs) in vitro, indicating the bioactivity of BMP-2. After finishing X-ray radiation of the radius bone, 20-mm radius bone defects were generated, followed by being implanted with BMP-2-releasing PLGA/GMs scaffolds with or without bone marrow. Both PLGA/GMs scaffolds containing bone marrow or BMP-2 showed more obvious enhancement for bone regeneration than the empty scaffolds (control) at the radius defect. In the X-ray radiated groups, however, the bone regeneration was inhibited either with bone marrow or BMP-2. When combined with bone marrow, the BMP-2 showed significantly high osteogenic effect, regardless of X-ray radiation. It is considered that it is a promising way to repair bone defects even after X-ray radiation by a combination of bone marrow with the BMP-2-releasing PLGA/GMs scaffold.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Bone Tissue Engineering Materials · Spine and Intervertebral Disc Pathology · Nerve injury and regeneration
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Orthopedics, Second Hospital of Jilin University
Department of Urology, First Hospital of Jilin University
Department of Orthopedics, China-Japan Union Hospital of Jilin University
Funding
the Program of Scientific Development of Jilin Province · the ‘Thirteen and Five’ Science and Technology Project of the Education Department of Jilin Province
References (54)
Show source-provided references
1. 10.1016/0278-2391(83)90294-X10.1016/0278-2391(83)90294-X ↗
2. 10.1097/00003086-200202000-0001110.1097/00003086-200202000-00011 ↗
3. 10.1016/j.oraloncology.2009.11.00610.1016/j.oraloncology.2009.11.006 ↗
4. 10.1126/science.849352910.1126/science.8493529 ↗
5. 10.1001/archotol.124.9.98510.1001/archotol.124.9.985 ↗
6. 10.1097/00001665-199803000-0000910.1097/00001665-199803000-00009 ↗
7. 10.3390/ijms1503364010.3390/ijms15033640 ↗
8. Wang NX, Zheng WF, Cheng SY, et al. In vitro evaluation of essential mechanical properties and cell behaviors of a novel polylactic-co-glycolic acid (PLGA)-based tubular scaffold for small-diameter vascular tissue engineering. Polym-Basel. 2017;9:318.
9. 10.1098/rsfs.2011.012310.1098/rsfs.2011.0123 ↗
10. 10.1007/s10856-012-4761-910.1007/s10856-012-4761-9 ↗
11. 10.1016/j.msec.2018.01.00810.1016/j.msec.2018.01.008 ↗
12. 10.1016/j.actbio.2012.11.00910.1016/j.actbio.2012.11.009 ↗
13. 10.1002/jbm.b.3400110.1002/jbm.b.34001 ↗
14. 10.1039/C7RA12062A10.1039/C7RA12062A ↗
15. An G, Zhang WB, Ma DK, et al. Influence of VEGF/BMP-2 on the proliferation and osteogenetic differentiation of rat bone mesenchymal stem cells on PLGA/gelatin composite scaffold. Eur Rev Med Pharmacol. 2017;21:2316–2328.
16. Zekorn D. Intravascular retention, dispersal, excretion and break-down of gelatin plasma substitutes. Bibl Haematol. 1969;33:131.
17. 10.1016/j.jddst.2017.04.01210.1016/j.jddst.2017.04.012 ↗
18. 10.1016/j.msec.2018.03.02910.1016/j.msec.2018.03.029 ↗
19. 10.1038/7944910.1038/79449 ↗
20. 10.2106/00004623-200206000-0002210.2106/00004623-200206000-00022 ↗
21. 10.1111/j.1365-2842.2008.01850.x10.1111/j.1365-2842.2008.01850.x ↗
22. 10.1016/j.biomaterials.2005.01.01210.1016/j.biomaterials.2005.01.012 ↗
23. 10.1016/S0142-9612(99)00207-010.1016/S0142-9612(99)00207-0 ↗
24. 10.1016/0011-9164(95)00076-310.1016/0011-9164(95)00076-3 ↗
25. 10.1016/j.biomaterials.2015.03.05710.1016/j.biomaterials.2015.03.057 ↗
26. 10.1089/ten.teb.2009.065810.1089/ten.teb.2009.0658 ↗
27. 10.1016/S0030-5898(20)30385-010.1016/S0030-5898(20)30385-0 ↗
28. 10.1016/j.ijbiomac.2015.08.00610.1016/j.ijbiomac.2015.08.006 ↗
29. 10.1098/rsif.2007.022010.1098/rsif.2007.0220 ↗
30. 10.1002/app.2814710.1002/app.28147 ↗
31. 10.1016/0032-3861(95)93115-310.1016/0032-3861(95)93115-3 ↗
32. 10.1002/adfm.20080066210.1002/adfm.200800662 ↗
33. Zhang N, Wang Y, Xu WP, et al. Poly(lactide-co-glycolide)/hydroxyapatite porous scaffold with microchannels for bone regeneration. Polym-Basel. 2016;8:216.
34. 10.3390/ma803100910.3390/ma8031009 ↗
35. 10.1016/j.ejpb.2012.08.00610.1016/j.ejpb.2012.08.006 ↗
36. 10.1088/1748-6041/7/6/06500110.1088/1748-6041/7/6/065001 ↗
37. 10.1016/j.biomaterials.2015.10.04310.1016/j.biomaterials.2015.10.043 ↗
38. 10.1007/s10856-011-4493-210.1007/s10856-011-4493-2 ↗
39. 10.1557/mrc.2017.9210.1557/mrc.2017.92 ↗
40. 10.1007/s10529-009-0100-810.1007/s10529-009-0100-8 ↗
41. 10.1126/science.150.3698.89310.1126/science.150.3698.893 ↗
42. 10.1007/s00264-007-0418-610.1007/s00264-007-0418-6 ↗
43. 10.1089/ten.tea.2013.035910.1089/ten.tea.2013.0359 ↗
44. 10.1007/s40005-017-0382-010.1007/s40005-017-0382-0 ↗
45. 10.1080/10717544.2018.144647310.1080/10717544.2018.1446473 ↗
46. 10.3390/ma904025910.3390/ma9040259 ↗
47. Al-Jarsha M, Moulisova V, Leal-Egana A, et al. Engineered coatings for titanium implants to present ultralow doses of BMP-7. ACS Biomater Sci Eng. 2018;4:1812–1819.
48. 10.1016/j.tripleo.2009.10.00110.1016/j.tripleo.2009.10.001 ↗
49. 10.1097/00006534-200010000-0001510.1097/00006534-200010000-00015 ↗
50. 10.1007/s00223990012910.1007/s002239900129 ↗
51. 10.1016/S0167-8140(98)00039-510.1016/S0167-8140(98)00039-5 ↗
52. 10.1038/946710.1038/9467 ↗
53. 10.1016/j.biomaterials.2008.10.05110.1016/j.biomaterials.2008.10.051 ↗
54. 10.1016/j.biomaterials.2010.12.05210.1016/j.biomaterials.2010.12.052 ↗